Study marks an important first step towards leveraging AI technology to reduce preventable harms, achieve better healthcare outcomes (Boston) — Generative artificial intelligence (genAI) uses hundreds of millions, sometimes billions, of data points to train itself to produce realistic and innovative outputs that can mimic human-created content. Its applications include personalized recommendations for online shoppers, […]
(Boston)—Genetic prion disease generally manifests with cognitive difficulties, poor muscle control and abrupt jerking movements of muscle groups and/or entire limbs. The three major phenotypes of genetic prion disease are genetic Creutzfeldt-Jakob disease (gCJD), fatal familial insomnia (FFI), and Gerstmann-Sträussler-Scheinker (GSS) syndrome. The most common cause of inherited prion diseases is the E200K mutation of […]
(Boston)—Stroke related to large vessel occlusion (LVO) is a leading cause of disability and death worldwide. Endovascular therapy (minimally invasive procedures like catheterization done inside the blood vessels) has transformed the management of these patients. In 2015, several randomized trials showed the benefit of endovascular therapy compared with medical management in reducing disability in some […]
(Boston)—Sickle cell disease is a common genetic disorder characterized by periodic occurrences of pain which happen repeatedly through life. These episodes, referred to as a vaso-occlusive episodes, happen when sickled cells obstruct blood vessels. The degree of pain may range from a mild discomfort to a severe disabling pain where the person needs treatment in […]
Understanding these differences can lead to better treatment strategies and improve the survival chances for patients with squamous cell carcinoma (Boston)—Cholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in people older than age 50. It is often diagnosed when it is advanced, making successful […]
(Boston)— The failure to diagnose Alzheimer’s disease, the most common form of dementia in the elderly, at an early stage of molecular pathology is considered a major reason why treatments fail in clinical trials. Previous research to molecularly diagnose Alzheimer’s disease yielded “A/T/N” central biomarkers based on the measurements of proteins, β-amyloid (“A”) and tau […]
(Boston)—Diana Anderson, MD, M.Arch, assistant professor of neurology at Boston University Chobanian & Avedisian School of Medicine, has received a one-year, $48,902 Bridging Bioethics Research & Policymaking grant from the Greenwall Foundation for her project “Improving Long-Term Care Facility Design through Bioethical Peer Review.” Anderson’s past research has shown that the built space of healthcare […]
Findings to serve as a reference for users and clinicians (Boston)—New continuous glucose monitoring sensors (small sensors that penetrate the skin to measure glucose levels in real time) are now hitting the wearables market for use among individuals without diabetes. Despite a lack of research showing that using these sensors improves health outcomes in individuals […]
First nationally representative analysis of suicide temporal trends among AAPI young adults across sexes over 21 years (Boston)—While suicide rates have decreased for white populations over the past two decades, they have increased in the Asian American Pacific Islander (AAPI) community. Yet, there are very little studies that examine trends of suicidal death across sexes […]
Technique provides a new approach that could improve patient outcomes, quality of life (Boston)—.Insulinomas are an abnormal tumor, usually benign, that grow in the beta cells of the pancreas. Insulinomas make extra insulin, more than the body can use. They can cause hypoglycemia, or low blood sugar. Low blood sugar can cause confusion, sweating, weakness, […]